Pharmacokinetics of leptin in mammals has received limited attention and only one study has 18 examined more than two time points and this was in ob/ob mice. This study is the first to observe the 19 distribution of leptin over a time course in female mice. A physiologic dose (12ng) of radiolabelled 20 leptin was injected in adult female mice via the lateral tail vein and tissues were dissected out and 21 measured for radioactivity over a time course up to two hours. Major targets for administered leptin 22 included the liver, kidneys, gastrointestinal tract and the skin while the lungs had high concentrations 23 of administered leptin per gram of tissue. Leptin was also found to enter the lumen of the digestive 24 tract intact from the plasma. Very little of the dose (< 1 %) was recovered from the brain at any time. 25
Introduction 36
Leptin is a 16 kDa cytokine originally identified as a hormone secreted from adipose tissue (Zhang et 37 al. 1994) but is also known to be synthesised in other tissues including the placenta (Masuzaki et al. 38 1997) , skeletal muscle (Wang et al. 1998 ) and the stomach (Bado et al. 1998) . Leptin circulates at 39 concentrations that correlate with fat mass (Considine et al. 1996) and signals via its alternately 40 spliced receptors (Lee et al. 1996) , notably LepRb, which has the greatest signalling capacity 41 (Bjørbaek et al. 1997) . Animals that lack functional leptin, ob/ob, or LepRb, db/db, express a 42 phenotype of voracious appetite and obesity and correction of the deficit corrects this (Campfield et 43 al. 1995 , de Luca et al. 2005 , Halaas et al. 1995 , Kowalski et al. 2001 , Pelleymounter et al. 1995 , 44 Weigle et al. 1995 . Furthermore, LepRb has been found to be expressed in the hypothalamus at high 45 density in nuclei thought to regulate energy balance (Chen et al. 1996 , Lee et al. 1996 . Consequently, 46 leptin was hypothesised to signal information from the periphery to the brain about energy stored as 47
Results

118
After intravenous administration of leptin to female mice at a physiologic dose, major targets were the 119 liver, kidneys, digestive tract and skin. Radiolabelled leptin was recovered from other tissues and 120 these were pooled as "other tissues". These tissues included the brain, submandibular salivary glands, 121 spleen, heart, lungs, ovaries, uterus and perirenal fat (figure 1). 122
Radiolabelled leptin from the blood, liver, kidneys and the pooled 'other tissues' was rapidly cleared 123 and was cleared from the skin slightly slower. Five minutes post-injection the blood contained 42.9 ± 124 0.8 % of the administered dose, the liver 19.5 ± 2.5 %, the kidneys 11.1 ± 1.1 %, skin 11.4 ± 0.3 % 125
and 'other tissues' 3.9 ± 0.1 % of the administered dose. The lungs contributed 19 -33 % of the 126 radiolabelled leptin recovered in the 'other tissues' over the duration of the experiment. In contrast, 127 between 5 and 60 minutes following administration the total radiolabelled leptin recovered from the 128 digestive tract (pooled with luminal contents) increased from 6.4 ± 1.3 % of the dose to 12.8 ± 0.7 % 129 of the dose before a slight decrease to 10.0 % of the dose 120 minutes after injection. The contents of 130 the small intestine (n = 2) were found to be 45.2 ± 1.6 % intact. The highest amount of radiolabelled 131 leptin recovered from the brain was 0.267 % of the dose 5 minutes after administration (data not 132 shown). 133
The total amount of radiolabelled leptin recovered from all examined tissues followed an exponential 134 decay pattern (figure 2). A total of 95.3 ± 5.9 % of the administered dose was recovered 5 min post-135 injection, declining to 54.3 ± 4.1 % 15 min post-injection and decreasing to 28.1 % of the dose 120 136 min after administration. Using these data whole body leptin kinetics were examined, revealing 137 administered leptin had a clearance rate of 0.23 ml/min/kg and a half-life of 47.3 min (table 1) in the 138 whole animal with an α phase half-life of 3.6 min and a β phase half-life of 150.0 min. 139 Radiolabelled leptin recovered from the blood rapidly dropped from 14.01 ± 0.38 % of the 140 administered dose per ml (dose/ml) 5 min post-injection to 5.28 ± 0.94 % of dose/ml 15 min after 141 administration. Following this a slower decline was seen to 3.09 % of dose/ml 120 min post-injection 142 (figure 3). Using these data the plasma clearance rate was calculated to be 1.58 ml/kg/min and the7 half-life of administered leptin in the plasma to be 32 minutes (table 1) with an α phase half-life of 2.9 144 min and a β phase half-life of 230.1 min. 145
In most of the tissues examined the radiolabelled leptin per gram of tissue (dose/g) decreased over the 146 course of the experiment. Five minutes after injection concentrations in the kidneys and liver 147 contained 22.71 ± 3.70 % of dose/g and 10.19 ± 1.34 % of dose/g, respectively, while the skin had 148 2.54 ± 0.10 % of dose/g. In the lungs a rapid drop was seen 5-15 min after administration from 7.69 ± 149 0.49 % of dose/g to 2.45 ± 0.45 % of dose/g; this then remained relatively stable until 60 min post- Generally, when radiolabelled leptin per gram of tissue was examined the pattern was similar to that 160 reported in total dose recovery above, with highest concentrations recovered from the blood ( figure  161 3), kidneys, liver, skin and perirenal fat (figure 4) and a decrease in radioactivity detected. One 162 notable difference was that the lungs displayed a high amount of radiolabelled leptin per gram. 163 164 8 Discussion 165
Leptin distribution was examined in female mice after intravenous injection of a physiologic dose of 166 radiolabelled leptin. The tissue distribution of radiolabelled leptin reported is similar in pattern to 167 those reported previously for intravenous administration in rats (Hill et al. 1998 ) and chickens 168 (McMurty et al. 2004) and following intraperitoneal administration in mice (Van Heek et al. 1996) . 169
The tissues where a high amount of radiolabelled leptin was recovered included the, kidneys, liver, 170 skin and gastrointestinal tract (and contents). Similar to the previous studies, it was found that the 171 brain was not a major target for leptin in these mice. In most of the tissues examined there appeared to 172 be an initial rapid clearance of leptin from the tissue before a slower phase of clearance. The 173 radiolabelled leptin was detected in all examined tissues up to the conclusion of the experiment 120 174 min after the injection. 175
Consistent with previous reports in several vertebrates (Hill et al. 1998 , McMurty et al. 2004 , Van 176 Heek et al. 1996 , very little of the administered leptin (< 1 % of the administered dose here) was 177 detected in the brain of the mice over the duration of the experiment. While on face value this may 178 seem to contradict the notion of leptin from the periphery playing a major role in the central nervous 179 system in the regulation of energy turnover and body mass (Friedman and Halaas 1998), it must be 180 noted that LepRb is found in the hypothalamus at relatively high density compared with most other 181 regions of the brain (Ghilardi et al. 1996 , Lee et al. 1996 , particularly in the arcuate, ventromedial, 182 dorsomedial, lateral and paraventricular nuclei, which are thought to be involved in appetite 183 regulation (Fei et al. 1997 , Mercer et al. 1996 . Furthermore, intravenously administered radiolabelled 184 leptin, albeit at a supraphysiologic dose, can be recovered from the arcuate nucleus of the 185 hypothalamus and the choroid plexus (Banks et al. 1996) . This may indicate that these hypothalamic 186 nuclei are extremely sensitive to the signalling of leptin from the periphery, which may be supported 187 by the intravenous and intraperitoneal administration of leptin to mice inducing STAT3 activation in 188 the hypothalamus at a physiologic dose (Vaisse et al. 1996) . However, as > 99% of the administered 189 dose of leptin was not recovered from the central nervous system it would appear that the major roles 190 for leptin lie in the periphery. 191 9
The total administered leptin recovered from the mice declined over the course of the experiment. 192 This is consistent with leptin being eliminated from the system via the kidneys (Cumin et al. 1996), 193 but also suggests that leptin may also enter tissues that were not sampled here. As 4.68 -71.92 % of 194 the administered dose was unaccounted for over the duration of the experiment some representative 195 samples of muscle were examined. In female mice skeletal muscle has been reported to account for 20 196 % of body mass (Griffin and Goldspink 1979) , if this were assumed and that 0.6 % of the dose was 197 recovered per gram of muscle (an approximation of the findings) there may be 4.55 % of the dose in 198 skeletal muscle over the entire animal. Both muscle (De Matteis et al. 1998 , Hoggard et al. 1997 , 199 Löllmann et al. 1997 and bone (osteoblasts and chondrocytes) express leptin receptors (Steppan et al. 200 2000) . In the muscle leptin attenuates insulin induced lipogenesis (Muoio et al. 1997 ) and stimulates 201 fuel oxidation (Dulloo et al. 2002 , Muoio et al. 1997 . In bone leptin has been shown to stimulate 202 growth in ob/ob mice (Steppan et al. 2000) , although centrally it appears to inhibit bone growth (Ducy 203 et al. 2000) . Therefore, it seems reasonable to speculate that a portion of the leptin not recovered over 204 the course of the experiments was sequestered into the musculoskeletal system. 205
The plasma half-life for the administered leptin in the plasma was found to be 32 min. This is 206 comparable with reported endogenous human leptin half-life, at 24.9 min (Klein et al. 1996) . The α 207 phase half-life, 2.9 min, is similar to reports in rats of approximately 5.1 min (Zeng et al. 1997) (Cumin et al. 1996) and is also higher than that reported for human leptin in rhesus monkeys of 214 96 min (Ahrén et al. 2000) . However, a number of these studies were performed at pharmacologic 215 doses ranging from 0.25 mg/kg (Cumin et al. 1996) to 10 mg/kg (Ahrén et al. 2000) . The clearance 216 from the blood reported is consistent with leptin removal by the kidneys, as has been identified as the 217 primary mechanism of elimination (Cumin et al. 1996 (Cumin et al. , 1997 . The reported data may have been 218 improved if the experiment was run over a longer period with more early time points, which may have 219 enabled the fitting of a third order exponential decay curve, as reported previously (Cumin et al. 220 1996) . Due to the sexual dimorphism of circulating leptin concentrations (Saad et al. 1997) it may be 221 interesting to determine whether the parameters examined here are similar in male mice. 222
Interestingly, the whole body half-life for administered leptin was approximately 1.5 times longer 223 than that for plasma borne leptin at 47.3 min, the reason for this is not clear. However, as 224 hypothesised previously (Hill et al. 1998 ) there seems to be a large pool of more slowly cleared leptin 225 that is thought to include leptin bound to receptors in tissues of the periphery . As indicated earlier, 226
the musculoskeletal system appears to be a target for leptin. Additionally, adipose tissue may retain 227 some peripheral leptin, although this may be transient, as indicated by the rapid drop in concentration 228 seen in the perirenal fat. Another large sink for circulating leptin was identified in the digestive tract, 229 with 12.8 % of the administered dose recovered 60 min after administration. This, as well as the slow 230 clearance from the blood 15-120 min after administration may indicate that leptin enters these tissues 231 for a period of time before re-entering the circulation. This possibility is supported by the finding that 232
LepRa-d facilitate the endocytosis and subsequent exocytosis of intact leptin from cells in vitro (Tu et 233 al. 2007 ). Further investigation would be needed to confirm this possibility. 234
Generally the pattern in total leptin recovery and leptin per gram in tissues examined followed a 235 similar pattern, with a notable exception in the lungs. The highest total recovery detected from the 236 lungs was 1.3 ± 0.01 % of the administered dose 5 min post-injection (data not shown), in comparison 237 > 10 % of the radiolabelled leptin administered was recovered from the blood, liver, kidneys, skin and 238 digestive tract, respectively, at various times observed. However, when concentration was examined 5 239 min post-injection 7.69 ± 0.49 % of dose/g was recovered from the lungs and only the blood, liver and 240 kidneys exhibited higher amounts per ml or gram. It is possible that a portion of the radiolabelled 241 leptin recovered from the lungs is actually in the blood, however cardiac puncture would be expected 242 to have removed most of this and the data presented are consistent with distribution reported in rats 243 (Hill et al. 1998) . This would seem to suggest that leptin plays a particularly important role in the 244 lungs. Leptin receptor mRNA is found at a relatively high abundance in the lungs (Ghilardi et al. 245 1996 , Löllmann et al. 1997 and both long and short isoforms are expressed as proteins in the tissue, 246 with immunohistochemistry showing club cells, muscle and veins stain strongly for LepRb (De 247 Matteis et al. 1998) . Furthermore, leptin has been shown to have physiologic effects in the lungs 248 including regulation of tissue maturation and possibly increasing surfactant secretion (Kirwin et al. 249 2006) . Radiolabelled leptin concentrations were apparently maintained at approximately 2.36 % 250 dose/g for 45 min during the experiment, possibly indicating that leptin has a normal maintenance 251 role in the lungs and as LepRb is expressed in club cells (De Matteis et al. 1998) , which can modulate 252 inflammation (Snyder et al. 2010) , this may be related to immune function. 253
The total recovery of exogenous leptin from the skin was examined for the first time and showed that 254 the skin is a major target for circulating leptin. Five min post-injection 11.4 ± 0.3% of the 255 radiolabelled leptin was detected in the skin. It should be noted that skin was removed intact from 256 animals with some underlying tissue and may therefore also be a proxy for subcutaneous fat, as leptin 257 is known to accumulate in fat (Ceccarini et al. 2009 , Li et al. 2013 . However, as the skin is the 258 largest organ of the body, it seems reasonable to suggest that with such a high recovery of the 259 administered dose from the tissue that this could be the skin itself. In support of this LepRb is 260 expressed in human fibroblasts (Glasow et al. 2001) . Leptin is capable of stimulating skin growth and 261 enhances wound healing, with LepRb expression reported at the margins of wound sites (Frank et al. 262 2000) . Furthermore, leptin has been found in the skin and is reduced in response to injury (Stallmeyer 263 et al. 2001) , coupled with the high proportion of leptin recovered from the skin here, leptin appears to 264 play a role in the maintenance of skin homeostasis. As a high concentration of leptin was also found 265 in the lungs and large amounts were in the digestive tract, all tissues that constitute the interface of the 266 body with the environment, it may be that leptin primes these tissues ready to respond to insult, but 267 more work would be required to confirm this. 268
In summary, plasma leptin half-life in female mice was found to be shorter than whole body half-life 269 and is presumed to be due to accumulation of leptin in peripheral tissues. A total of 12.8 % of the dose 270 was found to be in the digestive tract tissues and contents 60 min after administration, while 11.4 % 271 was recovered from the skin 5 min after administration, representing major targets for leptin in the 
